We are live on
!
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.15B
Turnover
18.82%
1-Year Est. Return
43.46%
This Fund
S&P 500
This Quarter
Est. Return
-0.76%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$307M
AUM Growth
+$31.9M
(+12%)
Cap. Flow
+$40.1M
Cap. Flow
% of AUM
13.06%
Top 10 Holdings %
Top 10 Hldgs %
24.74%
Holding
140
New
26
Increased
30
Reduced
34
Closed
7
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
+$9.59M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$6.03M |
| 3 |
GE Aerospace
GE
|
+$5.63M |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.15M |
| 5 |
Comcast
CMCSA
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$4.53M |
| 2 |
MacroGenics
MGNX
|
+$1.86M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$1.43M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$1.26M |
| 5 |
EOG Resources
EOG
|
+$1.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.28% |
| 2 | Communication Services | 20.72% |
| 3 | Energy | 14.2% |
| 4 | Industrials | 11.62% |
| 5 | Technology | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Johnson & Johnson
JNJ
$614B
| $2.13M | 0.69% |
21,855
+11,000
| +101% | +$1.1M |
2013 Q2
8 quarters
|
|
52
Liberty Media Corporation Series C Common Stock
FWONK
$22.8B
| $2.12M | 0.69% |
83,509
-481
| -0.6% | -$13K |
2014 Q3
3 quarters
|
|
53
RH
RH
$2.24B
| $2.03M | 0.66% |
+20,830
| New | +$1.92M |
2015 Q2
0 quarters
|
|
|
54
Ionis Pharmaceuticals
IONS
$7.22B
| $2.02M | 0.66% |
35,100
-71,220
| -67% | -$4.53M |
2014 Q4
2 quarters
|
|
55
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
| $1.85M | 0.6% |
107,378
+4,173
| +4% | +$71.9K |
2013 Q2
8 quarters
|
|
56
iShares Select Dividend ETF
DVY
$23.3B
| $1.74M | 0.57% |
23,175
| – | – |
2013 Q2
8 quarters
|
|
|
CELG
57
DELISTED
Celgene Corp
CELG
| $1.74M | 0.57% |
15,000
| – | – |
2013 Q2
8 quarters
|
|
58
MiMedx Group
MDXG
$674M
| $1.7M | 0.55% |
146,286
| – | – |
2013 Q2
8 quarters
|
|
59
Abbott
ABT
$183B
| $1.61M | 0.53% |
32,850
| – | – |
2013 Q2
8 quarters
|
|
60
DELISTED
Warner Bros
WBD
| $1.58M | 0.51% |
47,380
-4,100
| -8% | -$135K |
2014 Q3
3 quarters
|
|
|
DISCK
61
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.52M | 0.49% |
48,800
-5,100
| -9% | -$158K |
2014 Q3
3 quarters
|
|
|
MWV
62
DELISTED
MEADWESTVACO CORP
MWV
| $1.51M | 0.49% |
31,909
| – | – |
2013 Q2
8 quarters
|
|
|
DISH
63
DELISTED
DISH Network Corp.
DISH
| $1.5M | 0.49% |
22,200
+12,000
| +118% | +$839K |
2013 Q2
8 quarters
|
|
64
Gilead Sciences
GILD
$194B
| $1.31M | 0.43% |
11,194
| – | – |
2013 Q2
8 quarters
|
|
65
Vodafone
VOD
$37.3B
| $1.2M | 0.39% |
+32,916
| New | +$1.19M |
2015 Q2
0 quarters
|
|
66
Liberty Media Corporation Series A Common Stock
FWONA
$20.9B
| $1.11M | 0.36% |
45,927
+1,746
| +4% | +$45.1K |
2013 Q2
8 quarters
|
|
67
Omnicom Group
OMC
$22.5B
| $1.11M | 0.36% |
16,000
| – | – |
2013 Q2
8 quarters
|
|
68
CVR Partners
UAN
$1.4B
| $1.11M | 0.36% |
8,786
+495
| +6% | +$67.7K |
2013 Q2
8 quarters
|
|
|
MNDT
69
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.08M | 0.35% |
+22,000
| New | +$997K |
2015 Q2
0 quarters
|
|
70
EQT Corp
EQT
$33.2B
| $1.06M | 0.34% |
+23,859
| New | +$1.12M |
2015 Q2
0 quarters
|
|
71
Suncor Energy
SU
$90.1B
| $1.06M | 0.34% |
+38,367
| New | +$1.16M |
2015 Q2
0 quarters
|
|
|
RTN
72
DELISTED
Raytheon Company
RTN
| $1.02M | 0.33% |
+10,696
| New | +$1.12M |
2015 Q2
0 quarters
|
|
73
Wingstop
WING
$3.58B
| $994K | 0.32% |
+35,000
| New | +$1.01M |
2015 Q2
0 quarters
|
|
74
DELISTED
Liberty Broadband Class C
LBRDK
| $984K | 0.32% |
19,227
-94
| -0.5% | -$5.01K |
2014 Q4
2 quarters
|
|
75
Intuitive Surgical
ISRG
$152B
| $969K | 0.32% |
+18,000
| New | +$1.01M |
2015 Q2
0 quarters
|
|
Similar funds
WB
AIC
CFP
HT
AA
CIG
CIS
FWM
Private Capital Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, Private Capital Advisors held 140 positions worth $307M, up 12% from $275M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Private Capital Advisors deployed $40.1M of net new capital in Q2 2015, opening 26 new positions and adding to 30 existing holdings. Its largest new stake was Thermo Fisher Scientific: 46,230 shares worth $6M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $4.53M trimmed.
- Private Capital Advisors's largest Q2 2015 buy was Thermo Fisher Scientific: 46,230 shares worth $6M.
- Private Capital Advisors added most to Trillium Therapeutics Inc. in Q2 2015, an estimated $9.59M increase.
- Private Capital Advisors's biggest Q2 2015 reduction was Ionis Pharmaceuticals, cutting an estimated $4.53M.
- Private Capital Advisors fully exited Twitter, Inc. in Q2 2015, selling an estimated $1.43M.
- Private Capital Advisors's ten largest holdings make up 25% of its $307M portfolio in Q2 2015.
- Private Capital Advisors opened 26 new positions and closed 7 in Q2 2015.
- Private Capital Advisors's portfolio value rose 12% quarter-over-quarter to $307M.
Based on Private Capital Advisors's 13F filing for Q2 2015, filed 6 Aug 2015.